Cocaine-induced myocardial infarction: not your average acute coronary syndrome.
Behar
Jonathan M
JM
The Heart Hospital, UCL Hospitals, London.
Lindsay
Alistair C
AC
McEwan
Jean R
JR
D000077284:Abciximab; D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002637:Chest Pain / Q000139:chemically induced* / Q000188:drug therapy; D019970:Cocaine-Related Disorders / Q000150:complications* / Q000188:drug therapy; D016578:Crack Cocaine / Q000009:adverse effects*; D004359:Drug Therapy, Combination; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007140:Immunoglobulin Fab Fragments / Q000627:therapeutic use; D009203:Myocardial Infarction / Q000139:chemically induced* / Q000188:drug therapy; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D016578:Crack Cocaine; D007140:Immunoglobulin Fab Fragments; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D000077284:Abciximab